Papua New Guinea Country Profile
CDC began providing technical assistance to the Government of Papua New Guinea in 2007 and established an office there in 2012. CDC’s work in Papua New Guinea is focused on building a sustainable, country-owned response to the nation’s HIV and tuberculosis (TB) epidemics as well as strong health systems to support that response. CDC supports capacity building efforts around the design, implementation, and evaluation of HIV surveillance systems and improving national health information systems to collect, store, analyze, and use high-quality data essential to HIV prevention and treatment. In addition, CDC works with the nation’s Central Public Health Laboratory to strengthen laboratory systems essential to the HIV and TB response.
Per Capita GNI (2016)
54/1000 (2016)Live Births
Under 5 Mortality
66 years (2016)
(Ages 15-49): 0.9% (2016)
Estimated HIV Prevalence
Estimated AIDS Deaths
Reported Number Receiving Antiretroviral Therapy (ART)
Estimated TB Incidence
TB patients with known HIV-status who are HIV-positive
TB Treatment Success Rate
Centers for Disease Control and Prevention (CDC) has provided technical assistance (TA) to Papua New Guinea (PNG) since 2007 through cooperative agreements with the World Health Organization (WHO) and HEALTHQUAL to collaborate with the National Department of Health (NDOH), Provincial Health Authorities and other partners. The CDC-PNG Office was established in 2012 to build capacity and support health system strengthening to impact the PNG HIV/Tuberculosis (TB) epidemic.
Enhancing Surveillance and Health Information Systems: CDC builds in-country capacity to design, implement and evaluate HIV/AIDS surveillance systems and improve national health information systems to collect, store, analyze and use high-quality data essential to HIV prevention, and treatment decision-making.
Strengthening Health Systems: CDC partners with the NDOH and WHO to strengthen the local healthcare workforce in order to improve clinic quality, thus improving HIV treatment, the adoption and rollout of national HIV guidelines, and strengthening of organizational governance and management systems.
Strengthening Laboratory Systems: CDC collaborates with the NDOH and WHO for laboratory International Organization for Standardization (ISO) accreditation to improve HIV related testing. Through Technical Assistance (TA) provided to Central Public Health Laboratory (CPHL) of the NDOH, CDC-PNG works to increase testing capacity and improve test quality, timeliness and reporting. Laboratory priorities include quality assurance for rapid HIV testing and other related HIV testing, ensuring accurate results are provided to clients, and strategizing for scale-up of viral load testing.
Building Sustainable, Country-owned Programs- HIV Treatment Quality Improvement (QI): CDC in partnership with WHO PNG and HEALTHQUAL International, has assisted NDOH to formulate the national HIVQUAL framework, to improve the quality of HIV treatment through monitoring of quality indicators and implementing QI projects. Endorsement of HIVQUAL as a NDOH policy of HIV program emphasizes all stakeholders involved in HIV Treatment to improve quality.
Key Activities and Accomplishments
Field Epidemiology Training (FET): In collaboration with CDC, WHO and Australia’s Department of Foreign Affairs and Trade, the NDOH provides the annual four course FETPNG, which uses intensive mentoring and includes intervention projects that have already saved hundreds of lives. The NDOH considers the FETPNG its best program. It has trained 68 field epidemiologists working in the NDOH, provinces and districts providing new leadership in HIV and other disease surveillance, program monitoring, evaluation, reporting, and disease control activities. About one third of research projects and interventions of the FET fellows are associated with HIV, Tuberculosis (TB) and Sexually Transmitted Infections (STI) disease surveillance and control.
HIV Quality Improvement (HIVQUAL): HIVQUAL is the PNG standard tool for measuring and improving the quality of HIV patient treatment. The national HIVQUAL framework will serve as a platform to measure and improve quality of patient treatment, and monitor progress towards the UNAIDS 90:90:90 goals by 2030, both at the clinic level and the national level. Improving viral loading testing is the focus in 2018, along with improving retention in care and coverage of TB Preventive Therapy.
HIV Patient Database (HPDB): HPDB is one of the only clinic level patient management systems in PNG. CDC continues to support the expansion and rollout of the system by improving functionality, training users and analyzing and evaluating the data. CDC is leading efforts to develop a national level HPDB data hub for real time reporting and improved data use for decision-making.
TB (Non-PEPFAR): CDC-Headquarters is conducting a TB Patient Cost Survey in PNG to evaluate the magnitude, nature and drivers of catastrophic costs incurred by TB patients/households. The burden of TB diagnostic and treatment can have a devastating impact on patients and their families, and it is associated with poor treatment outcomes. One of the three core targets of the new World Health Organization End TB Strategy is no catastrophic costs for TB patients and their families due to TB diagnostic and treatment.